GRI BIO INC (GRI:NASDAQ)
$2.07 0.16 (8.377%)
Analysed GRI BIO INC (GRI:NASDAQ) News Sources
GRI Bio to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial
05-02-2026
yahoo.com
JTC Team Companies to Present in Webull Corporate Connect Webinar Series Happening February 10-11, 2026
09-02-2026
yahoo.com
GRI Bio CEO, Marc Hertz, Featured in Virtual Investor “What This Means” Segment
17-02-2026
yahoo.com
GRI Bio Receives Notice of Allowance for UAE Patent Application Covering Novel Type 2 Diverse NKT Cell Agonists for the Treatment of Inflammatory Conditions
08-04-2026
yahoo.com
GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
14-05-2026
yahoo.com
Grainger H1 Earnings Call Highlights
14-05-2026
marketbeat.com
GRI Bio Secures FDA Orphan Drug Designation for GRI-0621 (Tazarotene) in Idiopathic Pulmonary Fibrosis
18-06-2026
yahoo.com
GRI Bio to Present at A.G.P.’s Annual Healthcare Company Showcase
18-05-2026
yahoo.com
GRI Bio to Present Late-Breaking Phase 2a GRI-0621 Data Highlighting Lung Function, Anti-Fibrotic Biomarkers and Favorable Tolerability in IPF at ERS 2026
24-08-2026
yahoo.com
GRI Bio Featured in "Why Now" On-Demand Video Webcast
27-08-2026
yahoo.com
What is the current price of GRI BIO INC (GRI:NASDAQ)?
The current price of GRI BIO INC (GRI:NASDAQ) is $2.07.
GRI BIO INC (GRI:NASDAQ) absolute price change since previous trading day?
The absolute price change of GRI BIO INC (GRI:NASDAQ) since the previous trading day is $0.16.
GRI BIO INC (GRI:NASDAQ) percentage price change since previous trading day?
The percentage price change of GRI BIO INC (GRI:NASDAQ) since the previous trading day is 8.377%.
What is the most recent average sentiment score for GRI BIO INC (GRI:NASDAQ)?
The most recent average sentiment score for GRI BIO INC (GRI:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for GRI BIO INC (GRI:NASDAQ)?
The most recent sentiment for GRI BIO INC (GRI:NASDAQ) is .
SEC-8K** Filing Available For GRI BIO INC (GRI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.